Cargando…
N-Terminal Domain of Fragile Histidine Triad Exerts Potent Cytotoxic Effect in HT1080 Cells and Increases Doxorubicin Cytotoxicity
Fragile histidine triad (FHIT) serves a critical function as a tumor suppressor that inhibits p53 degradation by mouse double minute 2 (MDM2). The functional domains of FHIT involved in tumor inhibition was interpreted. In-silico screening data were employed to construct truncated forms of FHIT to a...
Autores principales: | Eslamparast, Ameneh, Abbasgholizadeh, Reza, Ostad, Seyed Nasser, Gharghabi, Mehdi, Ghahremani, Mohammad Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487436/ https://www.ncbi.nlm.nih.gov/pubmed/31089360 |
Ejemplares similares
-
In silico study of fragile histidine triad interaction domains with MDM2 and p53
por: Eslamparast, Ameneh, et al.
Publicado: (2014) -
The effect of full length and mature NAG-1 protein overexpression on cytotoxicity of celecoxib, tamoxifen and doxorubicin in HT1080
por: Barezi, S, et al.
Publicado: (2010) -
Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev
por: Niu, Zheyun, et al.
Publicado: (2023) -
The Clinical Relevance of Fragile Histidine Triad Protein (FHIT) in Patients with Bladder Cancer
por: Liu, Xiao-Ping, et al.
Publicado: (2018) -
Molecular and epigenetic analysis of the fragile histidine triad tumour suppressor gene in equine sarcoids
por: Strazzullo, Maria, et al.
Publicado: (2012)